Sort
17,828 grants matching “crispr”
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$526,422John D Gordan · University Of California, San Francisco · R37 · FY2022 · CA
Characterizing Human RPE Cell Proliferation to Advance Endogenous Regeneration
$526,346Sally Temple · Regenerative Research Foundation · R01 · FY2024 · EY
Mechanisms of Hedgehog signaling in glioblastoma
$526,287David R Raleigh · University Of California, San Francisco · R01 · FY2023 · CA
Multicell type human liver on chip microphysiological platform to examine CRISPR based gene modulation
$526,285Samira Kiani · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · DK
CRISPR-inhibition for FSHD
$526,259Peter L Jones · University Of Nevada Reno · R01 · FY2022 · AR
Regulation and Function of SRF in Vascular Pathiobiology
$526,257Joseph M Miano · Augusta University · R01 · FY2020 · HL
Evaluation of genetic variants affecting platelet function with CRISPR HDR in human megakaryocytes
$526,252Jesse Rowley · University Of Utah · R01 · FY2024 · HL
Mechanopriming for cell engineering
$526,102Song Li · University Of California Los Angeles · R01 · FY2025 · NS
Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitry
$525,941Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2022 · DA
Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitry
$525,941Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2024 · DA
Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitry
$525,941Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2023 · DA
Cell Envelope Biogenesis in Clostridioides difficile
$525,884Craig D Ellermeier · University Of Iowa · R01 · FY2021 · AI
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$525,822J. Silvio Gutkind · University Of California, San Diego · R01 · FY2023 · CA
Cis Regulatory Elements and Systemic Lupus Erythematosus
$525,796Joseph E Craft · Yale University · R01 · FY2020 · AR
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$525,766Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases
$525,747Jong-Min Lee · Massachusetts General Hospital · R01 · FY2018 · NS
Function and regulation of epithelial glycosylation
$525,698Jennifer J Kohler · Ut Southwestern Medical Center · R35 · FY2025 · GM
Function and regulation of epithelial glycosylation
$525,698Jennifer J Kohler · Ut Southwestern Medical Center · R35 · FY2024 · GM
Function and regulation of epithelial glycosylation
$525,698Jennifer J Kohler · Ut Southwestern Medical Center · R35 · FY2023 · GM
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
$525,697Paul J Brindley · George Washington University · R01 · FY2019 · CA
Epigenetic dysregulation in diabetic enteric neuropathy
$525,692Tamas Ordog · Mayo Clinic Rochester · R01 · FY2021 · DK
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis
$525,677Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
Approach for in vivo gene delivery into hematopoietic stem cells for hemophilia A therapy
$525,668Andre Michael Lieber · University Of Washington · R01 · FY2018 · HL
Off target mechanisms of kinase inhibitor toxicities
$525,584Navjot Pabla · Ohio State University · R01 · FY2022 · DK
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$525,419Saar Gill · University Of Pennsylvania · P01 · FY2025 · CA